---
title: "Coupang | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 8.504 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285303959.md"
datetime: "2026-05-06T03:23:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285303959.md)
  - [en](https://longbridge.com/en/news/285303959.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285303959.md)
---

# Coupang | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 8.504 B

Revenue: As of FY2026 Q1, the actual value is USD 8.504 B, missing the estimate of USD 8.616 B.

EPS: As of FY2026 Q1, the actual value is USD -0.15.

EBIT: As of FY2026 Q1, the actual value is USD -273 M.

### Q1 2026 Consolidated Financial Highlights

#### Gross Profit

Coupang, Inc. reported a gross profit of $2.3 billion for Q1 2026, marking a 1% decrease year-over-year (YoY) and remaining flat on a constant currency basis. The gross profit margin was 27.0%, a decrease of 228 basis points (bps) YoY.

#### Operating (Loss) Income

Operating loss was - $242 million in Q1 2026, a decrease of $396 million compared to the operating income in the prior year.

#### Net (Loss) Income Attributable to Coupang Stockholders

Net loss attributable to Coupang stockholders was - $266 million for Q1 2026, a decrease of $373 million from the net income reported last year.

#### Adjusted EBITDA

Adjusted EBITDA for the quarter was $29 million, with a margin of 0.3%, which is down 449 bps versus last year.

#### Operating Cash Flow

Operating cash flow for the trailing twelve months ended March 31, 2026, was $1.6 billion, representing a decrease of $425 million YoY. For Q1 2026, net cash provided by operating activities was $184 million, a 48% decrease from $354 million in Q1 2025.

#### Free Cash Flow

Free cash flow for the trailing twelve months ended March 31, 2026, was $301 million, a decrease of $724 million YoY. For Q1 2026, free cash flow was - $110 million, compared to $116 million in Q1 2025.

#### Stock Repurchases

Coupang, Inc. repurchased 20.4 million shares of Class A common stock for an aggregate amount of $391 million during Q1 2026. The Board of Directors also approved an additional $1 billion for the stock repurchase program.

### Q1 2026 Segment Highlights

#### Product Commerce Segment

-   **Net Revenues:** $7.2 billion, up 4% YoY on a reported basis and 5% YoY on a constant currency basis.
-   **Gross Profit:** $2.2 billion, up 1% YoY on a reported basis and 2% YoY on a constant currency basis. The gross profit margin was 30.3%, a decrease of 101 bps YoY.
-   **Adjusted EBITDA:** $358 million, down $192 million YoY, with a margin of 5.0%, down 302 bps YoY.
-   **Active Customers:** Product Commerce Active Customers grew to 23.9 million, an increase of 2% YoY.
-   **Net Revenues per Product Commerce Active Customer:** $300, up 2% YoY. On a constant currency basis, it was $303, up 3%.

#### Developing Offerings Segment

-   **Net Revenues:** $1.3 billion, up 28% YoY on a reported basis and 25% YoY on a constant currency basis.
-   **Gross Profit:** $123 million, a decrease of 25% YoY, and a decrease of 32% YoY on a constant currency basis.
-   **Adjusted EBITDA Losses:** - $329 million, an increase of $161 million YoY.

### Outlook / Guidance

The provided financial report does not include specific forward-looking numerical guidance for future periods. It contains a general statement regarding forward-looking statements that may include anticipated revenues, growth rates, margins, and cash flows, but no concrete figures are given.

### Related Stocks

- [CPNG.US](https://longbridge.com/en/quote/CPNG.US.md)

## Related News & Research

- [Coupang Director Kevin Warsh Resigns Following Fed Chair Confirmation](https://longbridge.com/en/news/286474920.md)
- [Ethic Inc. Grows Stock Holdings in Coupang, Inc. $CPNG](https://longbridge.com/en/news/286056046.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026 | OSTX Stock News](https://longbridge.com/en/news/286607728.md)